Art

J-GLOBAL ID：201202255073699075   Reference number：12A0368213

Reoxygenation of Glioblastoma Multiforme Treated with Fractionated Radiotherapy Concomitant with Temozolomide: Changes Defined by ¹⁸F-fluoromisonidazole Positron Emission Tomography: Two Case Reports

テモゾロミドを併用した分割放射線療法で治療した膠芽腫多形の再酸素負荷:¹⁸F-フルオロミソニダゾール陽電子放射断層撮影で規定された変化:2例の症例報告

Author (10)： NARITA Takuhito (Hokkaido Univ., Sapporo) ,  AOYAMA Hidefumi (Niigata Univ., Niigata) ,  HIRATA Kenji (Hokkaido Univ., Sapporo) ,  ONODERA Shunsuke (Hokkaido Univ., Sapporo) ,  SHIGA Tohru (Hokkaido Univ., Sapporo) ,  KOBAYASHI Hiroyuki (Hokkaido Univ., Sapporo) ,  MURATA Junichi (Sapporo Asabu Neurosurgical Hospital, Sapporo, JPN) ,  TERASAKA Shunsuke (Hokkaido Univ., Sapporo) ,  TANAKA Shinya (Hokkaido Univ., Sapporo) ,  HOUKIN Kiyohiro (Hokkaido Univ., Sapporo)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 42  Issue： 2  Page： 120-123  Publication year： Feb. 2012 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： ¹⁸F-FMISO PET ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0368213&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (2)： Tumors(=neoplasms)of nervous system  (GN04000V) ,  Radiotherapy for tumors  (GE03034K)

Substance index (2)： (18F)Fluoromisonidazole ,  Temozolomide

Reference (22)：

• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEngl JMed 2005; 352: 987-96.
• Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project. J Neurosurg 2003; 99: 467-73.
• Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 2008; 9: 29-38.
• Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638-48.
• Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev 2003; 29: 297-307.

Terms in the title (10)： テモゾロミド ,  併用 ,  放射線療法 ,  治療 ,  膠芽腫 ,  多形 ,  酸素 ,  陽電子放射断層撮影 ,  規定 ,  症例報告